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PHILOSOPHY OF BIOLOGY
Towards a classification
of stem cells
Abstract The characteristic properties of stem cells – notably their ability to self-renew and to
differentiate – have meant that they have traditionally been viewed as distinct from most other types
of cells. However, recent research has blurred the line between stem cells and other cells by showing
that the former display a range of behaviors in different tissues and at different stages of
development. Here, we use the tools of metaphysics to describe a classification scheme for stem
cells, and to highlight what their inherent diversity means for cancer treatment.
LUCIE LAPLANE AND ERIC SOLARY
I
n certain multicellular organisms, stem cells
can serve as reservoir of cells to produce,
maintain, repair or even regenerate many
tissues. Similarly, in cancer, a distinct fraction of
cells, called cancer stem cells, may fuel the
entire tumor as the disease emerges and pro-
gresses (Batlle and Clevers, 2017). How to
define, isolate or characterize both healthy and
cancer stem cells is a subject of much debate.
Here, we provide a philosophical analysis of
’stemness’ – the defining property of stem cells
– arguing that this approach may shed new light
on the nature of normal and malignant stem
cells. We show that, depending on the circum-
stances, stemness may belong to one out of four
distinct properties and discuss how this may
influence therapeutic strategies in the oncology
field.
One size does not fit all
Stem cells have been described as a discrete
population of cells sitting at the apex of a hierar-
chy of irreversible cell differentiation. This view
has had an impact on the way in which stem cell
research is performed by, for example, encour-
aging the idea that specific markers may help to
distinguish and sort stem cells. However,
researchers discovered that certain tissues
showed much more plasticity in cell fate than
anticipated. For example, it appeared that intes-
tinal cells could replace the stem cells tasked
with renewing the lining of the bowel
(Tetteh et al., 2016). Such flexibility suggested
that stemness might not be restricted to a pre-
defined population of cells and prompted some
biologists to question what stem cells really
were.
Traditional views of stem cells arose from
studies of the hematopoietic tissue in the bone
marrow, where blood cells originate in adults.
However, in the late 1970s, Ray Schofield sug-
gested that stemness actually relies on the inter-
action of hematopoietic stem cells (the cells that
give rise to other blood cells) with the microenvi-
ronment in which they reside (Schofield, 1978).
Although long denied, the importance of this
’niche’ is now increasingly accepted: hematopoi-
etic stem cells cannot be understood out of their
context, which may account for the difficulties in
maintaining them in culture.
Finally, new technologies, such as lineage
tracing, have further questioned the boundaries
of the stem cell category, as studies have shown
that not every individual hematopoietic stem cell
appears to be multipotent (discussed in
Haas et al., 2018). These analyses highlighted
that non-hematopoietic stem cells, called multi-
potent progenitors, could unexpectedly main-
tain the production of hematopoietic cells over
an extended period of time (Sun et al., 2014).
These are only a few of the examples that illus-
trate the potential diversity of these cells, which
has resulted in two opposite views of what a
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stem cell is: it can either be an entity, a discrete
population of cells with stable properties, or it
can be a cell state, a property that is acquired in
a specific context (e.g. Clevers and Watt, 2018;
Zipori, 2004).
Some order in the stemness mess
Philosophy, and more specifically metaphysics,
has a long tradition of characterizing and distin-
guishing different types of properties for the
objects or systems around us. We recently used
this tradition to characterize stemness and our
analysis led us to the conclusion that four types
of properties may exist under the guise of stem-
ness (Laplane, 2016; Laplane and Solary,
2017).
Stemness can be a ’categorical’ property,
that is, an intrinsic feature that is independent of
any interaction with surrounding entities, such as
the atomic mass of an element. It was initially
assumed that all stem cells belong to this class,
but, as discussed below, it might only apply to
certain cancers.
Alternatively, stemness can be a ’disposi-
tional’ property, which is also an intrinsic feature,
but one that only manifests upon interaction
with external stimuli. For example, a fragile item
only breaks on impact. Current knowledge sug-
gests that healthy hematopoietic stem cells fall
under this category. Although stemness is hard-
wired in these cells, it tightly depends on the
bone marrow niche. In a malignant context,
however, hematopoietic progenitor cells can
gain stemness as they transform into malignant
cells, questioning the maintenance of stemness
as a dispositional property.
Stemness can also be a ’relational’ property
that relies on the interaction between entities.
For example, body weight depends on gravity,
and differs on the Earth and the Moon. Unlike
the dispositional property, a relational property
is not hardwired in a predetermined pool of
cells, such as germline stem cells (which give rise
to egg and sperm cells). When these stem cells
are removed in fruit flies and mice, they are
replaced by differentiated cells that migrate
back to the stem cell niche, where they reac-
quire stemness (e.g. Brawley and Matunis,
2004). Stemness could also be a relational prop-
erty in some cancers: recent research in a mouse
model of colon cancer has revealed that after
cancer stem cells had been eliminated, some
remaining cancer cells regained stemness in the
primary tumor but not in liver metastases, sug-
gesting that a specific niche is required for the
acquisition of stemness (de Sousa e Melo et al.,
2017).
Finally, stemness can be a ’systemic’ prop-
erty, defined as an extrinsic characteristic that is
provided and maintained by the system. For
example, in the Matrix movie, every time the
main antagonist Agent Smith is killed, the sys-
tem transforms any human to incarnate the
agent. Likewise, stemness is a systemic property
when non-stem cells acquire stemness features
in the absence of a specific environment, which
may be the case in cancer. For example, some
differentiated cells from breast cancer cell lines
can become cancer stem cells again when cul-
tured in vitro (Gupta et al., 2011). This suggests
that stemness can be reacquired without a spe-
cific niche, with regulation taking place at the
system level – here, the cancer cell population.
Stemness therefore encompasses distinct
properties, depending on the tissue and con-
text. Which category a stem cell population
belongs to depends on two questions that can
be addressed experimentally: first, can stemness
be acquired by non-stem cells of that tissue?
And second, is the niche mandatory for the
acquisition of stemness, the expression
of stemness, or both?
Stemness in cancer
In oncology, the cancer stem cell model presup-
poses that cancers maintain an organization sim-
ilar to that of healthy tissues, with a pool of
malignant stem cells acting as the main reservoir
for the production of every other cell of the
tumor. These cells may be generated by the
transformation of typical stem cells in the tissue
of origin. The relationship between the rate of
stem cell division and the risk of malignant trans-
formation in a given tissue has led to much con-
troversy in recent years (Tomasetti et al., 2017;
Tomasetti and Vogelstein, 2015). Alternatively,
cancer stem cells may emerge from non-stem
cells endowed with stemness abilities thanks to
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genetic and epigenetic alterations. Similarities
and dissimilarities between normal stem cells
and cancer stem cells open three questions.
Firstly, is stemness the same in cancers and
their non-pathological counterparts? Some data
suggest that transformation can lead to, or rely
on, a transition between two types of stemness.
For instance, in some blood cancers known as
myeloproliferative neoplasms, hematopoietic
cells harboring the JAK2 V617F mutation (which
can be found in the majority of patients) secrete
a molecule that damages the hematopoietic
niche (Arranz et al., 2014). Only healthy, but
not malignant stem cells, are affected by the
degradation of their environment, which sug-
gests that upon transformation into leukemic
stem cells, normal stem cells become indepen-
dent to the niche. This moves stemness from a
dispositional property in healthy hematopoietic
stem cells to a categorical property in leukemic
stem cells.
Secondly, does stemness remain the same
type of property throughout disease progres-
sion? The JAK2 V617F mutation also contributes
to shifting stemness from a dispositional to a
categorical property by disrupting the regulation
of hematopoietic stem cells by their environment
(e.g., Staerk and Constantinescu, 2012). In
other myeloid malignancies, oncogenic events
such as KRAS mutations can lead to similar dys-
regulations. These mutations can occur either
very early in leukemic transformation, or later
during disease progression (Deininger et al.,
2017). This suggests that stemness transitioning
from a dispositional to a categorical property
could also happen during the clonal evolution of
the disease.
Lastly, is stemness the same type of property
in all types of cancers of a particular tissue? In
mouse models of squamous cell carcinoma, a
type of skin cancer, cells gain migratory and
invasive properties through a mechanism known
as a epithelial-to-mesenchymal transition. This
process can occur either frequently or rarely,
depending on the chromatin state of the cell of
origin (Latil et al., 2017). As this transition can
result in stemness acquisition, squamous cell car-
cinomas may fall into two categories. In the
absence of transition, stemness would best
described as a dispositional property: intrinsic to
the cells, but only revealed in the right context.
However, in the presence of frequent transitions,
stemness would become a relational property –
extrinsic and conditional on epithelial-to-mesen-
chymal transitions.
Taken together, cancer occurrence and pro-
gression could be associated with changes in
the nature of stemness. It remains to be seen
whether these changes are a consequence of
disease progression or one of its requirements.
How stemness categorization may
drive therapeutic choices
How is this philosophical characterization of
stemness useful for science and medicine? We
suggest that in oncology, the four types of stem-
ness properties require different therapeutic
strategies. Current treatment approaches target
either malignant cells (with chemotherapy, ioniz-
ing radiations and targeted therapies), or sur-
rounding cells (with immunotherapy or anti-
angiogenic therapies). If these treatments fail to
eliminate all the cancer stem cells, a relapse may
occur. Choosing to target either cancer stem
cells, their niche, or both, relies on implicit pre-
suppositions regarding stemness.
Targeting cancer stem cells depends on the
assumption that stemness is an intrinsic property
(i.e., categorical or dispositional); otherwise, the
malignant cells would regenerate new cancer
stem cells after their elimination. Niche-targeting
relies on the notion that stemness is a niche-
dependent property (i.e., dispositional or rela-
tional). Accordingly, each type of stemness may
determine the choice of a therapeutic approach:
. If stemness is a categorical property, only
strategies that target cancer stem cells will
be efficient.
. If stemness is a dispositional property,
approaches that focus on both cancer
stem cells and their niches may be used.
. If stemness is a relational property, only
niche-targeting strategies will be poten-
tially useful.
. If stemness is a systemic property, none of
the therapeutic strategies aiming at eradi-
cating cancer stem cells or their niche will
be efficient, as the system (the cancer cell
population) may instruct any tumor cell to
become a cancer stem cell, without requir-
ing any specific niche.
Stemness encompasses distinct
properties, depending on the tissue
and context
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Changes in the nature of stemness may
require therapeutic adaptation. It would thus be
useful to monitor the impact of genetic and epi-
genetic alterations on the nature of stemness
during the evolution of the disease. If changes in
stemness are driving progression rather than
resulting from it, therapeutic interventions that
modulate stemness could also be beneficial.
Perspective: is philosophy useful
to science?
Stem cell biology is full of conceptual
debates, and philosophers have contributed to
these debates on a range of topics (reviewed in
Fagan, 2013b), including the definition of stem
cells and the entity/state debate (Fagan, 2013a;
Laplane, 2016; Wilson et al., 2007;
Leychkis et al., 2009). Focusing on the nature
of stemness, we show how traditional tools of
philosophy, such as the
metaphysics of properties, can be applied to
stem cell biology to shed light on the fundamen-
tal nature of stem cells. More than a simple
descriptive characterization, the proposed classi-
fication draws practical consequences in guiding
the choice of an anticancer treatment. Many
questions remain unsolved, however. If stemness
is not one but four different properties, are we
right to use only one name? Are all the cells that
we call stem cells, really stem cells? Do they
share some underlying characteristics that justify
their biological clustering, or is ’stem cell’ just a
convenient category to group cell types that are
actually distinct?
While experimental biology will hardly answer
these questions, phylogeny, on the other hand,
could be helpful. For instance, mammals and
insects have distinct types of eyes that have
emerged independently throughout evolution as
two different but effective solutions to a similar
challenge. Similarly, a phylogenetic analysis of
stemness could highlight whether the different
types of stem cells occurred separately during
evolution, as different solutions to the chal-
lenges of tissue maintenance and repair. In turn,
this would deepen the metaphysics of stem cells
by identifying whether our four stemness prop-
erties depict entities that are biologically inde-
pendent . It is only by bridging disciplines such
as experimental biology, medicine, phylogeny
and philosophy that stem cells will be properly
understood.
Note
This Feature Article is part of the Philosophy of
Biology collection.
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